Literature DB >> 20629541

Transforming growth factor β, bone morphogenetic protein, and vascular endothelial growth factor mediate phenotype maturation and tissue remodeling by embryonic valve progenitor cells: relevance for heart valve tissue engineering.

Yung-Nung Chiu1, Russell A Norris, Gretchen Mahler, Andrew Recknagel, Jonathan T Butcher.   

Abstract

Despite years of research, limited understanding of heart valve cell and tissue biology remains a key impediment to valvular tissue engineering progress. Heart valves rapidly evolve structural and cellular composition naturally during embryonic development, which suggests that mimicking these signaling events could advance engineered valve tissue research. Many inductive factors participate in the initial endocardial to mesenchymal transformation event necessary to form the prevalvular cushion, but far less is known about the regulation of cushion remodeling into fibrous leaflets and the associated maturation of valvular progenitors into fibroblasts. In this study, we combine in vitro three-dimensional tissue-engineered models of embryonic valvular remodeling with in vivo analysis to determine the roles of three prominent growth factors during avian mitral valvulogenesis. We show that transforming growth factor-β3 (TGFβ3), bone morphogenetic protein 2 (BMP2), and vascular endothelial growth factor A (VEGFA) are expressed in spatiotemporally distinct patterns and at significantly different levels within remodeling embryonic valves in vivo. We then establish dose-dependent functional roles for each growth factor in 3D cultured embryonic valve progenitor cells. TGFβ3 induced cell migration, invasion, and matrix condensation; BMP2 induced invasion. VEGFA inhibited invasion but increased migration. Finally, we determine that TGFβ3 induced myofibroblastic differentiation in a dose-dependent manner, whereas VEGFA and BMP2 did not. Collectively, these findings frame a naturally derived blueprint for controlling valvulogenic remodeling and phenotype maturation, which can be integrated into clinically needed regenerative strategies for heart valve disease and to accelerate the development of engineered tissue valves.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20629541      PMCID: PMC2965198          DOI: 10.1089/ten.tea.2010.0027

Source DB:  PubMed          Journal:  Tissue Eng Part A        ISSN: 1937-3341            Impact factor:   3.845


  37 in total

1.  Optimal cell source for cardiovascular tissue engineering: venous vs. aortic human myofibroblasts.

Authors:  A M Schnell; S P Hoerstrup; G Zund; S Kolb; R Sodian; J F Visjager; J Grunenfelder; A Suter; M Turina
Journal:  Thorac Cardiovasc Surg       Date:  2001-08       Impact factor: 1.827

2.  Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: final report of the Veterans Affairs randomized trial.

Authors:  K Hammermeister; G K Sethi; W G Henderson; F L Grover; C Oprian; S H Rahimtoola
Journal:  J Am Coll Cardiol       Date:  2000-10       Impact factor: 24.094

Review 3.  Heart valve development: endothelial cell signaling and differentiation.

Authors:  Ehrin J Armstrong; Joyce Bischoff
Journal:  Circ Res       Date:  2004-09-03       Impact factor: 17.367

Review 4.  Mechanisms involved in valvuloseptal endocardial cushion formation in early cardiogenesis: roles of transforming growth factor (TGF)-beta and bone morphogenetic protein (BMP).

Authors:  Y Nakajima; T Yamagishi; S Hokari; H Nakamura
Journal:  Anat Rec       Date:  2000-02-01

5.  Evaluation of biodegradable, three-dimensional matrices for tissue engineering of heart valves.

Authors:  R Sodian; S P Hoerstrup; J S Sperling; D P Martin; S Daebritz; J E Mayer; J P Vacanti
Journal:  ASAIO J       Date:  2000 Jan-Feb       Impact factor: 2.872

6.  Thoracic Surgery Directors Association Award. Bone marrow as a cell source for tissue engineering heart valves.

Authors:  Tjörvi E Perry; Sunjay Kaushal; Fraser W H Sutherland; Kristine J Guleserian; Joyce Bischoff; Michael Sacks; John E Mayer
Journal:  Ann Thorac Surg       Date:  2003-03       Impact factor: 4.330

7.  Defective valvulogenesis in HB-EGF and TACE-null mice is associated with aberrant BMP signaling.

Authors:  Leslie F Jackson; Ting Hu Qiu; Susan W Sunnarborg; Aileen Chang; Chunlian Zhang; Cam Patterson; David C Lee
Journal:  EMBO J       Date:  2003-06-02       Impact factor: 11.598

8.  Dynamic and reversible changes of interstitial cell phenotype during remodeling of cardiac valves.

Authors:  Elena Rabkin-Aikawa; Mark Farber; Masanori Aikawa; Frederick J Schoen
Journal:  J Heart Valve Dis       Date:  2004-09

9.  Porcine aortic valve interstitial cells in three-dimensional culture: comparison of phenotype with aortic smooth muscle cells.

Authors:  Jonathan T Butcher; Robert M Nerem
Journal:  J Heart Valve Dis       Date:  2004-05

10.  A novel role for VEGF in endocardial cushion formation and its potential contribution to congenital heart defects.

Authors:  Y Dor; T D Camenisch; A Itin; G I Fishman; J A McDonald; P Carmeliet; E Keshet
Journal:  Development       Date:  2001-05       Impact factor: 6.868

View more
  14 in total

Review 1.  EMT-inducing biomaterials for heart valve engineering: taking cues from developmental biology.

Authors:  M K Sewell-Loftin; Young Wook Chun; Ali Khademhosseini; W David Merryman
Journal:  J Cardiovasc Transl Res       Date:  2011-07-13       Impact factor: 4.132

2.  Cyclic Mechanical Loading Is Essential for Rac1-Mediated Elongation and Remodeling of the Embryonic Mitral Valve.

Authors:  Russell A Gould; Huseyin C Yalcin; Joanna L MacKay; Kimberly Sauls; Russell Norris; Sanjay Kumar; Jonathan T Butcher
Journal:  Curr Biol       Date:  2015-12-24       Impact factor: 10.834

Review 3.  The heterogeneous biomechanics and mechanobiology of the mitral valve: implications for tissue engineering.

Authors:  K Jane Grande-Allen; Jun Liao
Journal:  Curr Cardiol Rep       Date:  2011-04       Impact factor: 2.931

4.  Association of TGFBR2 rs6785358 Polymorphism with Increased Risk of Congenital Ventricular Septal Defect in a Chinese Population.

Authors:  Xiang-Ting Li; Chang-Qing Shen; Rui Zhang; Ji-Kui Shi; Zong-Hong Li; Hong-Yu Liu; Bo Sun; Kai Wang; Li-Ru Yan
Journal:  Pediatr Cardiol       Date:  2015-05-30       Impact factor: 1.655

Review 5.  Filamin-a-related myxomatous mitral valve dystrophy: genetic, echocardiographic and functional aspects.

Authors:  Aurélie Lardeux; Florence Kyndt; Simon Lecointe; Hervé Le Marec; Jean Merot; Jean-Jacques Schott; Thierry Le Tourneau; Vincent Probst
Journal:  J Cardiovasc Transl Res       Date:  2011-07-20       Impact factor: 4.132

6.  Synthesis and characterization of tunable poly(ethylene glycol): gelatin methacrylate composite hydrogels.

Authors:  Che B Hutson; Jason W Nichol; Hug Aubin; Hojae Bae; Seda Yamanlar; Shahed Al-Haque; Sandeep T Koshy; Ali Khademhosseini
Journal:  Tissue Eng Part A       Date:  2011-04-12       Impact factor: 3.845

7.  Serotonin and catecholamines in the development and progression of heart valve diseases.

Authors:  Elliott Goldberg; Juan B Grau; Jacqueline H Fortier; Elisa Salvati; Robert J Levy; Giovanni Ferrari
Journal:  Cardiovasc Res       Date:  2017-07-01       Impact factor: 10.787

8.  Myocardial contraction and hyaluronic acid mechanotransduction in epithelial-to-mesenchymal transformation of endocardial cells.

Authors:  Mary Kathryn Sewell-Loftin; Daniel M DeLaughter; Jon R Peacock; Christopher B Brown; H Scott Baldwin; Joey V Barnett; W David Merryman
Journal:  Biomaterials       Date:  2014-01-14       Impact factor: 12.479

9.  New technologies for surgery of the congenital cardiac defect.

Authors:  David Kalfa; Emile Bacha
Journal:  Rambam Maimonides Med J       Date:  2013-07-25

10.  Serotonin potentiates transforming growth factor-beta3 induced biomechanical remodeling in avian embryonic atrioventricular valves.

Authors:  Philip R Buskohl; Michelle J Sun; Michelle L Sun; Robert P Thompson; Jonathan T Butcher
Journal:  PLoS One       Date:  2012-08-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.